Mode
Text Size
Log in / Sign up
N/A N=139 Randomized Other

Cigarette Smoking Among Young Adults

Cigarette Smoking · Smoking Behaviors

Enrolled (actual)
139
Serious AEs
0.0%
Results posted
Aug 2025
Primary outcome: Primary: Puff Topography — 1108; 1045.2; 1084.6 mL

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Very low nicotine cigarette: menthol (Other); Very low nicotine cigarette: non-mentol (Other)
Age
Adult · 18+ yrs
Sex
All
Sponsor
University of Oklahoma
Primary completion
Mar 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Puff Topography
1108; 1045.2; 1084.6
PRIMARY
Ratings of Psychological Reward
3.1; 2.9; 2.3
PRIMARY
Hypothetical Purchasing of Non-Menthol Very Low Nicotine Cigarettes (VLNCs)
20.40; 6.11; 14.44; 3.66; 10.17; 3.37
SECONDARY
Exhaled CO Boost
4.08; 3.72; 3.9; 9.17; 7.65; 6.79

Summary

This study will examine perceptions and smoking behavior of menthol and non-menthol very low nicotine cigarettes in young adult smokers. The aims are to examine perceptions and smoking behavior in the laboratory and in the natural environment. A separate sub-sample of men and women who identify as LGBTQ2S+ will also be recruited.

Eligibility Criteria

Inclusion Criteria

  • Ages18 to 34;
  • Smoke cigarettes "somedays" or "everyday" for at least the past 3-months;
  • A strong preference for menthol cigarettes (i.e., smoke menthol >80% of the time); and
  • Ability to read English at an 8th grade level or higher;
  • No immediate plans to quit smoking.

Exclusion Criteria

  • Current use of nicotine replacement therapy (NRT);
  • Pregnant or planning to become pregnant, or currently breastfeeding;
  • Past or current self-reported clinically significant heart disease or hypertension, or other smoking-related disease (by history) that preclude successful study completion;
  • Serious psychiatric disorder;
  • Inability to abstain from nicotine/tobacco products;
  • Strong preference for non-menthol cigarettes (smoke non-menthol > 80% of the time)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04340947). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search